Prices as of 2025-11-26 16:20:40 ET
Ticker Appearances
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Insurance stocks and Homebuilders both have appeal in the weeks ahead
MARKETS REMAIN IN A TRICKY SPOT HEADING INTO THANKSGIVING WEEK, AND TODAY’S BOUNCE FAILED TO SHOW SUFFICIENT IMPROVEMENT TO THINK A LOW OF ANY MAGNITUDE...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - November 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
NVDA earnings look critical as US Equities near "Make-or-Break"
US EQUITY TRENDS REMAIN CHOPPY, BUT ARGUABLY HAVE NOT BROKEN DOWN IN A WAY THAT SHOULD GIVE WAY TO MUCH MORE TECHNICAL WEAKNESS. BOTH SPX...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Small-cap underperformance likely could reverse later this week
US EQUITY TRENDS REMAIN CHOPPY, BUT BULLISH, AND BOTH SPX AND QQQ LOOK TO BE STABILIZING NEAR KEY SUPPORT, WHICH LIKELY CAN LEAD TO A...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Energy U-turn likely points to meaningful drop in Crude by year-end
NEAR-TERM US EQUITY TRENDS ARE BULLISH, BUT I EXPECT EQUITIES HAVE ENTERED A CHOPPIER ENVIRONMENT, WHICH MIGHT REQUIRE SOME CONSOLIDATION BEFORE SPX CAN PUSH BACK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Insurance stocks and Homebuilders both have appeal in the weeks ahead
MARKETS REMAIN IN A TRICKY SPOT HEADING INTO THANKSGIVING WEEK, AND TODAY’S BOUNCE FAILED TO SHOW SUFFICIENT IMPROVEMENT TO THINK A LOW OF ANY MAGNITUDE...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - November 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
NVDA earnings look critical as US Equities near "Make-or-Break"
US EQUITY TRENDS REMAIN CHOPPY, BUT ARGUABLY HAVE NOT BROKEN DOWN IN A WAY THAT SHOULD GIVE WAY TO MUCH MORE TECHNICAL WEAKNESS. BOTH SPX...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Small-cap underperformance likely could reverse later this week
US EQUITY TRENDS REMAIN CHOPPY, BUT BULLISH, AND BOTH SPX AND QQQ LOOK TO BE STABILIZING NEAR KEY SUPPORT, WHICH LIKELY CAN LEAD TO A...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Energy U-turn likely points to meaningful drop in Crude by year-end
NEAR-TERM US EQUITY TRENDS ARE BULLISH, BUT I EXPECT EQUITIES HAVE ENTERED A CHOPPIER ENVIRONMENT, WHICH MIGHT REQUIRE SOME CONSOLIDATION BEFORE SPX CAN PUSH BACK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Medical Device names now breaking out to join Biotechnology
NEAR-TERM TREND REMAINS NEGATIVE FOR SPX UNTIL 6770 CAN BE EXCEEDED, AND DESPITE THE TWO-DAY BOUNCE, MORE WILL BE NEEDED TO HELP RESTORE THE TECHNICAL...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Insurance stocks and Homebuilders both have appeal in the weeks ahead
MARKETS REMAIN IN A TRICKY SPOT HEADING INTO THANKSGIVING WEEK, AND TODAY’S BOUNCE FAILED TO SHOW SUFFICIENT IMPROVEMENT TO THINK A LOW OF ANY MAGNITUDE...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - November 2025
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
NVDA earnings look critical as US Equities near "Make-or-Break"
US EQUITY TRENDS REMAIN CHOPPY, BUT ARGUABLY HAVE NOT BROKEN DOWN IN A WAY THAT SHOULD GIVE WAY TO MUCH MORE TECHNICAL WEAKNESS. BOTH SPX...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Small-cap underperformance likely could reverse later this week
US EQUITY TRENDS REMAIN CHOPPY, BUT BULLISH, AND BOTH SPX AND QQQ LOOK TO BE STABILIZING NEAR KEY SUPPORT, WHICH LIKELY CAN LEAD TO A...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Energy U-turn likely points to meaningful drop in Crude by year-end
NEAR-TERM US EQUITY TRENDS ARE BULLISH, BUT I EXPECT EQUITIES HAVE ENTERED A CHOPPIER ENVIRONMENT, WHICH MIGHT REQUIRE SOME CONSOLIDATION BEFORE SPX CAN PUSH BACK...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Articles Read 2/2
🎁 Unlock 1 extra article by joining our Community!
You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.
Already have an account? Sign In ed92af-417ac8-e69d04-4c2746-2864af
Already have an account? Sign In ed92af-417ac8-e69d04-4c2746-2864af